Recruiting

Movement Behaviours Among Bahraini Diabetics

ClinicalTrials.gov IDNCT06069258

PhaseNot Applicable

Enrollment340

SponsorRoyal College of Surgeons in Ireland - Medical University of Bahrain

Age20 Years

SexALL

I'm interested View official listing

Conditions studied

Diabetes Mellitus, Type 2

About this study

This observational study aims to measure movement behaviours and explore factors influencing these among Bahraini patients with type 2 diabetes. The main objectives are: (i) Measure free-living physical activity and sedentary behaviour with an accelerometer device (ii) Examine associations between movement behaviours and anthropometric and diabetes-related biochemical/clinical parameters (iii) Examine associations between movement behaviours and psychological and environmental determinants that influence movement behaviours (iv) Assess the feasibility and acceptability of the physical activity assessment tools as part of routine clinical practice with clinicians and diabetic patients Participants will be invited to wear an accelerometer device for seven days.

Primary outcomes

Movement behaviour (1 week (duration of the study))

Eligibility information

Inclusion Criteria: * Sex: Men and women are eligible. * Age: Individuals aged 20-75 years old are eligible. * Ethnicity: Bahraini adults of all ethnic groups are eligible for the study. * Type 2 diabetes and glycaemic control: Individuals with controlled type 2 diabetes (i.e. HbA1c \<9 on medication) based on the medical record of each patient's last visit to the health centre for routine follow-up will be eligible if within the last four months. Otherwise, these measurements will be ordered at the first visit to confirm eligibility. * Blood pressure: Individuals whose blood pressure is under moderate control will be eligible - specifically, treated or untreated resting systolic/diastolic pressure \< 160/100 mmHg. * Lipid control: Individuals with fasting triglyceride concentration \< 600 mg are eligible. Exclusion Criteria: * HbA1c \>9% * Type 1 diabetes * Taking insulin * Pregnancy * Non-ambulant or severely incapacitated with any medical condition(s) reducing ability to stand or mobilize. * Currently participating in a study to reduce sedentary behaviour or increase physical activity * Language. Inability to read and understand Arabic or English language. * Inability to give informed consent.

Study locations

Isa Town Health Centre, Building 10, Road 43, Manama Block 743 Bahrain
Ahmed Ali Kanoo Health Centre, Building 2009, Road 2641, Manama Block 626 Bahrain
Halat Bu Maher Health Centre, Building 2858, Road 1653, Muharraq Block 216 Bahrain
Shaikh Jaber AlSabah Health Centre, Building 6347, Road Nakheel Street, Northern Governorate Block 518 Bahrain

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.